Bio-Path Holdings Inc
BPTH
BPTH was delisted on the 18th of February, 2025.
13 hedge funds and large institutions have $285K invested in Bio-Path Holdings Inc in 2024 Q2 according to their latest regulatory filings, with 4 funds opening new positions, 2 increasing their positions, 1 reducing their positions, and 1 closing their positions.
300% more first-time investments, than exits
New positions opened: 4 | Existing positions closed: 1
263% more capital invested
Capital invested by funds: $78.6K → $285K (+$207K)
100% more repeat investments, than reductions
Existing positions increased: 2 | Existing positions reduced: 1
30% more funds holding
Funds holding: 10 → 13 (+3)
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
AC
Armistice Capital
New York
|
+$266K |
| 2 |
HF
HRT Financial
New York
|
+$38.6K |
| 3 |
Geode Capital Management
Boston,
Massachusetts
|
+$29.8K |
| 4 |
TRCT
Tower Research Capital (TRC)
New York
|
+$4.93K |
| 5 |
Qube Research & Technologies (QRT)
London,
United Kingdom
|
+$274 |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
UBS Group
Zurich,
Switzerland
|
-$872 |
| 2 |
Wells Fargo
San Francisco,
California
|
-$20 |
| Name | Holding | Trade Value |
Shares Change |
Change in Stake |
|
|---|---|---|---|---|---|
|
AC
1
Armistice Capital
New York
| $194K | +$266K | +97,000 | New |
|
|
HF
2
HRT Financial
New York
| $28K | +$38.6K | +14,085 | New |
|
3
Vanguard Group
Malvern,
Pennsylvania
| $27K | – | – | – |
|
|
4
Geode Capital Management
Boston,
Massachusetts
| $21.7K | +$29.8K | +10,866 | New |
|
|
TRCT
5
Tower Research Capital (TRC)
New York
| $7.47K | +$4.93K | +1,799 | +93% |
|
6
BlackRock
New York
| $4.76K | – | – | – |
|
|
7
UBS Group
Zurich,
Switzerland
| $1.72K | -$872 | -318 | -27% |
|
|
8
Qube Research & Technologies (QRT)
London,
United Kingdom
| $200 | +$274 | +100 | New |
|
9
Bank of America
Charlotte,
North Carolina
| $92 | +$107 | +39 | +557% |
|
10
Morgan Stanley
New York
| $70 | – | – | – |
|
11
Group One Trading
Chicago,
Illinois
| $42 | – | – | – |
|
|
GRP
12
Global Retirement Partners
San Rafael,
California
| $8 | – | – | – |
|
|
AF
13
Allworth Financial
Folsom,
California
| $2 | – | – | – |
|
|
14
Wells Fargo
San Francisco,
California
| – | -$20 | -5 | Closed |
|
BPTH Hedge Fund Activity: Q2 2024 in Review
13 of the 6,924 institutional investors tracked by Wall St. Rank reported a position in Bio-Path Holdings Inc (BPTH) for Q2 2024, worth a combined $285K — up 263% from $78.6K a quarter earlier.
Buyers outnumbered sellers: 4 funds opened new BPTH positions and 1 closed out — a net gain of 3 holders — while 2 added to existing stakes and 1 trimmed.
The largest buyer was Armistice Capital, opening a new position worth an estimated $266K. The largest seller was UBS Group, cutting an estimated $872.
- 13 institutional investors held Bio-Path Holdings Inc (BPTH) as of Q2 2024, up from 10 in Q1 2024.
- Funds reported $285K of Bio-Path Holdings Inc stock for Q2 2024, up 263% quarter-over-quarter.
- 4 funds opened new Bio-Path Holdings Inc positions in Q2 2024 and 1 closed out, a net change of +3 holders.
- The largest Bio-Path Holdings Inc buyer in Q2 2024 was Armistice Capital, an estimated $266K added.
- The largest Bio-Path Holdings Inc seller in Q2 2024 was UBS Group, an estimated $872 sold.
Based on aggregated 13F filings for Q2 2024.